Antibody data
- Antibody Data
- Antigen structure
- References [5]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN952697 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Histone Deacetylase 11 (HDAC11) (AA 196-226), (Middle Region) antibody
- Antibody type
- Polyclonal
- Description
- Protein A column, followed by peptide affinity purification
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- AA 196-226, Middle Region
- Vial size
- 0.4 mL
- Storage
- Store undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Differential histone deacetylase mRNA expression patterns in amyotrophic lateral sclerosis.
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance.
From immunity to tolerance through HDAC.
Acetylation/deacetylation modulates the stability of DNA replication licensing factor Cdt1.
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo.
Janssen C, Schmalbach S, Boeselt S, Sarlette A, Dengler R, Petri S
Journal of neuropathology and experimental neurology 2010 Jun;69(6):573-81
Journal of neuropathology and experimental neurology 2010 Jun;69(6):573-81
The histone deacetylase HDAC11 regulates the expression of interleukin 10 and immune tolerance.
Villagra A, Cheng F, Wang HW, Suarez I, Glozak M, Maurin M, Nguyen D, Wright KL, Atadja PW, Bhalla K, Pinilla-Ibarz J, Seto E, Sotomayor EM
Nature immunology 2009 Jan;10(1):92-100
Nature immunology 2009 Jan;10(1):92-100
From immunity to tolerance through HDAC.
Georgopoulos K
Nature immunology 2009 Jan;10(1):13-4
Nature immunology 2009 Jan;10(1):13-4
Acetylation/deacetylation modulates the stability of DNA replication licensing factor Cdt1.
Glozak MA, Seto E
The Journal of biological chemistry 2009 Apr 24;284(17):11446-53
The Journal of biological chemistry 2009 Apr 24;284(17):11446-53
MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo.
Fournel M, Bonfils C, Hou Y, Yan PT, Trachy-Bourget MC, Kalita A, Liu J, Lu AH, Zhou NZ, Robert MF, Gillespie J, Wang JJ, Ste-Croix H, Rahil J, Lefebvre S, Moradei O, Delorme D, Macleod AR, Besterman JM, Li Z
Molecular cancer therapeutics 2008 Apr;7(4):759-68
Molecular cancer therapeutics 2008 Apr;7(4):759-68
No comments: Submit comment
Supportive validation
- Submitted by
- antibodies-online (provider)
- Main image
- Experimental details
- WB